Description:
Kio Medical has developed a software that relies on the susceptibility induced signal loss on T2*-weighted sequences which results from a bolus of gadoliniumbased contrast passing through a capillary bed. The most commonly calculated parameters in this software are rCBV, rCBF, and MTT as dynamic susceptibility contrast-enhanced MR perfusion, still abbreviated to DSC.
This software also noninvasively characterizes tumor biology allowing for the diagnosis and therapeutic monitoring of glioma.

Disease:
❖ Solid tumor
❖ Prostate cancer
❖ Rectal cancer
❖ Endometrial cancer
❖ Liver cancer

Related Contents:

Perfusion Imaging

Perfusion Imaging Perfusion is a fundamental biological function that refers to the delivery of oxygen and nutrients to

Read More »
error:
Scroll to Top